Revenue
2022
2023
2024
2025
Abingdon Health plc (ABDX)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £8.4M | £6.1M | £4.0M | £2.8M |
| Gross profit | £3.7M | £3.7M | £2.1M | −£3.6M |
| Gross margin | 44.32% | 59.97% | 51.30% | −126.70% |
| Operating expenses | £7.2M | £5.1M | £5.7M | £17.9M |
| Operating income | −£3.5M | −£1.4M | −£3.6M | −£21.5M |
| Operating margin | −41.63% | −22.38% | −88.70% | −759.37% |
| EBITDA | −£2.8M | −£916,000 | −£2.8M | −£19.9M |
| EBITDA margin | −33.23% | −14.93% | −69.49% | −701.48% |
| Net income | −£3.4M | −£1.3M | −£3.5M | −£21.3M |
| Net profit margin | −40.51% | −20.72% | −85.76% | −749.98% |
| Basic EPSper basic share | -£0.01 | -£0.00 | -£0.01 | -£0.07 |
| Diluted EPSper diluted share | -£0.01 | -£0.00 | -£0.01 | -£0.07 |
Owners
Reported ownership